{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-033073","form_type":"8-K","ticker":"OLMA","cik":"0001750284","company_name":"Olema Pharmaceuticals, Inc.","filed_at":"2025-03-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.712550+00:00","generated_at":"2026-05-25T10:50:12.732958+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Olema Pharmaceuticals posts investor presentation with no material new disclosures","bullets":["Company made investor presentation available on its website on March 5, 2025.","Presentation title: 'Advancing medicines for breast cancer and beyond'.","No specific financial or clinical updates provided in the filing.","Presentation appears to be a standard corporate overview.","Confidence low due to lack of substantive details in exhibit."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-033073","json":"https://secwatch.observer/filing/0000950170-25-033073.json","markdown":"https://secwatch.observer/filing/0000950170-25-033073.md","text":"https://secwatch.observer/filing/0000950170-25-033073.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1750284/000095017025033073/0000950170-25-033073-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1750284/000095017025033073/olma-20250305.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T10:50:12.732958+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}